ASTRO Annual Refresher Course registrants who add the Radiopharmaceutical Therapy course to their registration will be able to access the course approximately three weeks prior to the Annual Refresher Course. The course can be accessed in the ASTRO Academy under your My Activities Pending activities and will remain available to you until the course expires in early 2024.
You can add the Radiopharmaceutical Therapy Course when you register for the 2023 Annual Refresher Course.
Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies. This course focuses on clinical indications, difficult cases, medical physics considerations, development of standard operating procedures for clinical implementation and billing and troubleshooting theranostic delivery. Specifically, Radium-223, Lutetium-177 dotatate and Lutetium-177 PSMA-617 are discussed. The course includes didactic presentations from physician experts from radiation oncology, nuclear medicine and medical oncology and medical physicists, with question and answer sessions to discuss practice implementation in various clinical settings (i.e., academic hospital vs community practice, nuclear medicine vs radiation oncology). The purpose of the course is to increase physician, physicist, billing and administration understanding on how to effectively and safely develop a radiopharmaceutical program at their respective institutions.
| Topic | Presenters |
|---|---|
| Introduction to Radiopharmaceutical Therapy | Annick Van den Abbeele, MD |
| Basics of Physics and Radiobiology for Radiopharmaceutical Therapies – Emerging Research | Stephen Graves, PhD Zachary Morris, MD, PhD |
| Case Presentation and Discussion | Ana Kiess, MD, PhD |
Lu-177-PSMA (Prostate)
| Jeff Michalski, MD, MBA, FASTRO Jacqueline Zoberi, PhD |
| Case Presentation and Discussion | Ana Kiess, MD, PhD |
Lu-177-Dotatate (NET)
| Amir Iravani, MD Nicole Maughan, PhD, MS |
| Case Presentation and Discussion | Hyun Kim, MD |
